Background: Vortioxetine (VRX) is a multimodal antidepressant that acts as serotonin (5HT) transporter inhibitor as well as 5HT3A and 5HT7 receptors antagonist, 5HT1A and 5HT1B receptors partial agonist. It was recently approved in the US and the EU for the treatment of adult patients with Major Depressive Disorder (MDD). Objective: The present article aims at systematically reviewing findings of the published and unpublished research on the pharmacological properties, efficacy, safety and tolerability of oral VRX in the treatment of MDD. Method: A systematic review, in accordance with the Cochrane Collaboration and the PRISMA guidelines, was conducted searching the electronic databases MEDLINE, by combining the following keyterms: ((vortio...
Major depressive disorder; Substance use disorder; VortioxetineTrastorno depresivo mayor; Trastorno ...
Depression and anxiety disorders are two of the most common mental illnesses experienced by people w...
Major depressive disorder, a common debilitating illness, is one of the leading causes of disability...
Background: Vortioxetine (VRX) is a multimodal antidepressant that acts as serotonin (5HT) transport...
Vortioxetine (VRX) is a multimodal antidepressant that acts as serotonin (5¬HT) transporter inhibito...
Vortioxetine is a novel antidepressant drug approved for the treatment of major depressive disorder ...
Introduction: Vortioxetine is a novel antidepressant drug approved for the treatment of major depres...
Major depressive disorder (MDD) is a common psychiatric disorder with an estimated lifetime prevalen...
AbstractVortioxetine, a novel antidepressant for the treatment of major depressive disorder (MDD), i...
Vortioxetine is a new multimodal action antidepressant with two types of action: serotonin transport...
Introduction: Vortioxetine is a multimodal-acting antidepressant that provides improvements on cogni...
Notwithstanding the high prevalence, functional burden, negative consequences and risk of chronicity...
Vortioxetine is indicated for the treatment of moderate to severe major depressive episodes. The cli...
Roger S McIntyre1,2 1Department of Psychiatry, University of Toronto, 2Mood Disorders Psychopharmac...
Background: Efficacy has been proven for vortioxetine in short-term and long-term treatment of major...
Major depressive disorder; Substance use disorder; VortioxetineTrastorno depresivo mayor; Trastorno ...
Depression and anxiety disorders are two of the most common mental illnesses experienced by people w...
Major depressive disorder, a common debilitating illness, is one of the leading causes of disability...
Background: Vortioxetine (VRX) is a multimodal antidepressant that acts as serotonin (5HT) transport...
Vortioxetine (VRX) is a multimodal antidepressant that acts as serotonin (5¬HT) transporter inhibito...
Vortioxetine is a novel antidepressant drug approved for the treatment of major depressive disorder ...
Introduction: Vortioxetine is a novel antidepressant drug approved for the treatment of major depres...
Major depressive disorder (MDD) is a common psychiatric disorder with an estimated lifetime prevalen...
AbstractVortioxetine, a novel antidepressant for the treatment of major depressive disorder (MDD), i...
Vortioxetine is a new multimodal action antidepressant with two types of action: serotonin transport...
Introduction: Vortioxetine is a multimodal-acting antidepressant that provides improvements on cogni...
Notwithstanding the high prevalence, functional burden, negative consequences and risk of chronicity...
Vortioxetine is indicated for the treatment of moderate to severe major depressive episodes. The cli...
Roger S McIntyre1,2 1Department of Psychiatry, University of Toronto, 2Mood Disorders Psychopharmac...
Background: Efficacy has been proven for vortioxetine in short-term and long-term treatment of major...
Major depressive disorder; Substance use disorder; VortioxetineTrastorno depresivo mayor; Trastorno ...
Depression and anxiety disorders are two of the most common mental illnesses experienced by people w...
Major depressive disorder, a common debilitating illness, is one of the leading causes of disability...